myBiometry
4 known investors
MyBiometry offers a patented at-home sensor and device that measures airway inflammation through fractional exhaled nitric oxide (FeNO) in a person's breath. The biomarker data is used to assess attack risk, medication adherence and efficacy, and exposure to environmental triggers for respiratory conditions.
Digital HealthHardwareMedical Devices